Find out which companies are making headlines in the dining industry.
AMC Entertainment – Shares fell 14.8% after the company proposed a stock split and announced another $110 million capital increase in an effort to minimize its leverage. Shares of its preferred stock rose more than 64%.
You are here – Shares fell more than 9% in Thursday’s session. Tesla offered a $7,500 discount on its Model 3 and Model Y vehicles delivered in the US at the end of the year, as well as 10,000 free boost miles for those vehicles, according to its website.
Micron technology — The semiconductor stock fell 5% after the company shared disappointing quarterly results and revenue, which it attributed to slowing demand expected to continue through 2023. Micron also announced it would cut its workforce by 10% next year. Other chip stocks, including Nvidia and Advanced Micro Devices, fell 9% and 7%, respectively. Marvell Technology fell more than 5%.
CarMax – The auto retailer’s shares fell 6.6% after its earnings and revenue last quarter missed Wall Street expectations. CarMax earned 24 cents per share on $6.51 billion in revenue. Analysts had expected earnings of 70 cents per share on $7.29 billion in revenue.
under protection – The stock fell more than 4% on Thursday. The athletic apparel maker has announced that Stephanie Linnartz, the current president of Marriott International, will join the company as CEO in 2023.
TuSimple – Shares fell more than 12% after TuSimple said it would cut 25% of its workforce, affecting about 350 employees at the self-driving truck startup.
Airline stocks – A number of airlines fell on Thursday amid news of hundreds of flight cancellations as a massive winter storm hit the US and United fell 5.5% and 4% respectively. Delta and Southwest fell at least 3%.
Tyson Foods – Shares of Tyson Foods fell 1.9% after the Wall Street Journal reported that the meat and poultry producer is expected to lose hundreds of employees as it consolidates its offices next year.
MillerKnoll – MillerKnoll rose more than 7% after reporting second-quarter fiscal 2023 results and revenue beat expectations. The office furniture maker also said it was able to achieve annual expense reductions of $30 million to $35 million, which will begin to be realized in the third quarter and more fully in the fourth quarter.
Mirati Therapeutics – Shares rose 2.2% after the FDA granted the drugmaker’s colorectal cancer treatment a “breakthrough therapy” designation.
— CNBC’s Sarah Min contributed reporting